ROCHESTER, N.Y., Dec. 20 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. , the Pittsford, NY-based leader of image-related biomarkers, announced today that it has been awarded two research contracts from the Department of Defense totaling $2.65 million to explore the application of VirtualScopics proprietary image analysis technologies to the interpretation of optical hyper-spectral reconnaissance and surveillance imagery. “Hyper-spectral cameras break up incoming light into hundreds or thousands of individual spectral bands, yielding valuable information about trace chemicals in the atmosphere as well as the chemical makeup of objects on the ground,” explained VirtualScopics researcher Dr. Edward Ashton. “However, extracting this information requires complex processing and considerable analyst time. We believe our software tools will streamline this process and make it both more accurate and more efficient.”
“This may seem to be a bit outside our core areas of expertise,” said VirtualScopics’ President and CEO Robert Klimasewski. “But the image analysis problems faced by Department of Defense researchers are actually similar in many ways to those of our core customers in the pharmaceutical industry. I think the confidence the DoD has shown in us is strong testament to the power and utility of the technology we have developed.”
Senator Hillary Clinton, from New York, said, “I’m pleased that the Defense Appropriations Conference committee recognizes the value of VirtualScopics’ innovative technologies. One of my top priorities as a Senator for New York is to support New York companies that can make a contribution to our national defense.”
About VirtualScopics, Inc.
VirtualScopics, Inc. is a provider of advanced medical image analysis services. The company evolved from research first carried out at the University of Rochester Medical Center and School of Engineering. VirtualScopics has created a suite of image analysis tools used in detecting and analyzing specific structures in volumetric medical images, as well as characterizing minute changes in structures over time, providing vital information to support clinical trials and diagnostic applications. The firm’s proprietary software algorithms can assemble hundreds of separate medical images taken during an MRI session into a single, three-dimensional model, bringing a new and previously unobtainable source of data to clinical researchers. For more information about VirtualScopics, visit http://www.virtualscopics.com.
Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. Forward-looking statements deal with the Company’s current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission.
Contact: Tracy Bagatelle-Black of Bagatelle-Black Public Relations for VirtualScopics, Inc., +1-661-263-1842 or tracy@bagatelleblack.com
VirtualScopics, Inc.
CONTACT: Tracy Bagatelle-Black for VirtualScopics, Inc., +1-661-263-1842or tracy@bagatelleblack.com
Web site: http://www.virtualscopics.com//
